Fed. Circ. Reverses Ax Of Novartis Patent Due To 1995 Law
The Federal Circuit on Friday reversed a lower court decision invalidating a Novartis AG patent on the cancer drugs Zortress and Afinitor, saying that a 1995 law changing the length of...To view the full article, register now.
Already a subscriber? Click here to view full article